
|Articles|September 1, 2003
Cyclosporine drops useful in topical steroid-resistant eyes
Fort Lauderdale, FL-Cyclosporine A drops may be an effective treatment for Thygeson's superficial punctate keratitis (SPK) over the long term. It is especially useful in patients whose disease does not respond to treatment with steroids or those whose disease responds to steroids and who have elevated IOP levels, according to the results of a U.K. study reported at the Association for Research in Vision and Ophthalmology.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
ONL Therapeutics reports positive phase 1b data for xelafaslatide in geographic atrophy
2
FDA feedback supports Azura’s Ophthalmic's planned NDA for AZR-MD-001 in MGD
3
Alcon raises offer in amended deal to acquire STAAR Surgical
4
Neurotrophic keratitis outcomes improve with early, stage-based care
5













































.png)


